Progress of FDA’s Office of Combination Products

By MedTech Intelligence Staff
No Comments

What are the challenges faced by OCP?

Bradley Merrill Thompson, partner at Epstein, Becker & Green, discusses the Office of Combination Products and its development over the past decade, as well as the challenges it faces in the area of policy making, at MedTech Intelligence’s 2015 Combination Products Conference in Washington, DC.

After viewing the video, learn more about his thoughts on the alignment between OCP and CDRH, CDER, and CBER  as well as the role of human factors in combination products.

Leave a Reply

Your email address will not be published. Required fields are marked *

For security, use of Google's reCAPTCHA service is required which is subject to the Google Privacy Policy and Terms of Use.

I agree to these terms.